✦ LIBER ✦

Protracted treatment with tegafur and low dose oral leucovorin in patients with advanced colorectal carcinoma

✍ Scribed by Alvaro S. Rubiales; M. Luisa del Valle

Publisher: John Wiley and Sons
Year: 1999
Tongue: English
Weight: 59 KB
Volume: 85
Category: Article
ISSN: 0008-543X
DOI: 10.1002/(sici)1097-0142(19990415)85:8<1866::aid-cncr29>3.0.co;2-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Protracted treatment with tegafur and lo

Protracted treatment with tegafur and low dose oral leucovorin in patients with advanced colorectal carcinoma

✍ Miquel Nogué; Miquel A. Seguí; Eugeni Saigí; Eduard Batiste-Alentorn; Angels Arc 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB 👁 2 views

## BACKGROUND. Protracted oral administration of tegafur (TG) and leucovorin (LV) attempts to simulate the continuous infusion of 5-fluorouracil, with a higher intracellular folate pool. In a prior dose-finding study with a fixed TG dose of 0.75 g/m 2 /day for a period of 21 days and continuous or

Hypocalcemia associated with 5-fluoroura

Hypocalcemia associated with 5-fluorouracil and low dose leucovorin in patients with advanced colorectal or gastric carcinomas

✍ Yuichiro Kido; Takeshi Okamura; Morimasa Tomikawa; Manabu Yamamoto; Morio Shirai 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 367 KB 👁 2 views

## BACKGROUND. The biochemical modulation of 5-fluorouracil (5-FU) by leucovorin (Lv) has demonstrated significantly increased response rates in comparison with the use of 5-FU alone in patients with advanced colorectal carcinoma. However, the higher response rate of LV/5-FU may occur at the expen

Phase II trial of epirubicin, cisplatin,

Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma

✍ Yoon T. Jeen; So Y. Yoon; Sang W. Shin; Byung S. Kim; Young J. Mok; Chong S. Kim 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 2 views

Phase II study of oral eniluracil, 5-flu

Phase II study of oral eniluracil, 5-fluorouracil, and leucovorin in patients with advanced colorectal carcinoma

✍ Neal J. Meropol; Donna Niedzwiecki; Donna Hollis; Richard L. Schilsky; Robert J. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 2 views

Uracil and tegafur modulated with leucov

Uracil and tegafur modulated with leucovorin : An effective regimen with low toxicity for the treatment of colorectal carcinoma in the elderly

✍ J. Feliu; M. González Barón; E. Espinosa; C. García Girón; I. de la Gándara; J. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 1 views

## BACKGROUND. In spite of the high prevalence of cancer in the elderly

Bimonthly high dose leucovorin and 5-flu

Bimonthly high dose leucovorin and 5-fluorouracil 48-hour continuous infusion in patients with advanced colorectal carcinoma

✍ Karine Beerblock; Yves Rinaldi; Thierry André; Christophe Louvet; Eric Raymond; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 1 views

with low dose LV. Based on these reports, a first-line Phase II study was performed in 101 patients with advanced colorectal carcinoma who were given a bimonthly